User profiles for W.J. Koh

Won-Jung Koh

Samsung Medical Center
Verified email at skku.edu
Cited by 21443

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

…, S Keshavjee, FA Khan, M Kipiani, SP Koenig, WJ Koh… - The Lancet, 2018 - thelancet.com
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs, …

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis

…, S De Lorenzo, G Ferrara, WJ Koh… - European …, 2012 - Eur Respiratory Soc
Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of
systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety …

[HTML][HTML] Update on pulmonary disease due to non-tuberculous mycobacteria

JE Stout, WJ Koh, WW Yew - International Journal of Infectious Diseases, 2016 - Elsevier
Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of chronic
pulmonary infection, posing a number of challenges for both clinicians and researchers. …

Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology

WJ Koh, NR Abu-Rustum, S Bean, K Bradley… - Journal of the National …, 2019 - jnccn.org
Cervical cancer is a malignant epithelial tumor that forms in the uterine cervix. Most cases of
cervical cancer are preventable through human papilloma virus (HPV) vaccination, routine …

[HTML][HTML] Delamanid for multidrug-resistant pulmonary tuberculosis

…, J Chang, K Suzuki, T Tupasi, WJ Koh… - … England Journal of …, 2012 - Mass Medical Soc
Background Delamanid (OPC-67683), a nitro-dihydro-imidazooxazole derivative, is a new
antituberculosis medication that inhibits mycolic acid synthesis and has shown potent in vitro …

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study

…, M Jankovic, E Jong, J Keane, WJ Koh… - European …, 2013 - Eur Respiratory Soc
A significant knowledge gap exists concerning the geographical distribution of nontuberculous
mycobacteria (NTM) isolation worldwide. To provide a snapshot of NTM species …

[HTML][HTML] Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

…, LG Jarlsberg, S Keshavjee, HR Kim, WJ Koh… - 2012 - journals.plos.org
Background Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic,
expensive, and has generally poor outcomes. We undertook an individual patient data meta-…

Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology

WJ Koh, NR Abu-Rustum, S Bean, K Bradley… - Journal of the National …, 2018 - jnccn.org
Endometrial carcinoma is a malignant epithelial tumor that forms in the inner lining, or
endometrium, of the uterus. Endometrial carcinoma is the most common gynecologic malignancy. …

Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No …

…, LM Jampol, JM Kirkwood, WJ Koh… - … (Chicago, Ill.: 1960), 2005 - europepmc.org
Objective To describe the time between treatment for choroidal melanoma and first diagnosis
of metastatic disease, sites of metastasis, treatments for metastasis, and time between …

Imaging of hypoxia in human tumors with [F-18] fluoromisonidazole

WJ Koh, JS Rasey, ML Evans, JR Grierson… - International Journal of …, 1992 - Elsevier
Fluoromisonidazole (FMISO) has been shown to bind selectively to hypoxic cells in vitro and
in vivo at radiobiologically significant oxygen levels. When labeled with the positron emitter …